Fasting and Ketogenic Diet Reset Fat Production Pathways in Obese Adults
Czech study reveals how strategic fasting and ketogenic diets can reprogram harmful fat production in obesity.
20 articles
Czech study reveals how strategic fasting and ketogenic diets can reprogram harmful fat production in obesity.
Major study shows lifestyle intervention effectively reverses prediabetes in both African American and Caucasian participants with family diabetes history.
Study reveals how lean people can still have obesity-like metabolism and whether calorie restriction helps reverse this dangerous condition.
16-week study explores how 8-hour eating windows affect different types of obesity and metabolic health markers.
A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.
German researchers test whether natural foods plus digital coaching can match diabetes remission rates of formula diets.
Duke study shows high-quality egg protein combined with calorie restriction improves metabolic outcomes in older adults with prediabetes.
176-person study explored personalized responses to refined carbs, whole grains, and intermittent fasting for optimal glucose control.
A completed OSU trial investigates whether short-term exercise training can restore impaired mitochondrial cleanup pathways in overweight and obese skeletal muscle.
UCSF study tests whether eating within specific time windows can help obese adults lose weight more effectively than traditional dieting.
A completed Danish trial investigates how blocking IL-6 signaling with tocilizumab alters fat, glucose, and protein metabolism in humans.
Study reveals how newborn care disrupts mothers' circadian rhythms, potentially affecting long-term metabolic health and diabetes risk.
A Phase IIa trial explores whether the HIF-PHI drug daprodustat can safely replace EPO injections in hemodialysis patients with anemia.
New study reveals how endurance exercise transforms fat-burning brown adipose tissue in just six weeks of training.
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
Australian study compares calorie restriction with time-restricted eating for reducing diabetes and heart disease risk factors.
Small study explores whether eating within 9-hour windows can improve blood sugar control and metabolic health in diabetic patients.
43 overweight adults followed intermittent fasting with 25% calorie reduction, measuring fat loss, muscle preservation, and metabolic changes.
169-person study tests whether intermittent fasting and low-carb approaches can reverse insulin resistance and metabolic dysfunction.
Swiss researchers studied how mTOR protein in fat tissue affects metabolism and insulin function throughout the body.